Clinical Trial: Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting
Brief Summary: This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.
Detailed Summary:
Sponsor: Novartis Pharmaceuticals
Current Primary Outcome:
- Serum Creatinine and liver enzyme levels [ Time Frame: 3 years ]Observed over 3 years for each patient
- Adverse Drug Reactions [ Time Frame: 3 years ]Observed over 3 years for each patient
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Novartis
Dates:
Date Received: July 12, 2011
Date Started: July 2011
Date Completion:
Last Updated: February 1, 2016
Last Verified: February 2016